A. V. Sorokina

A. V. Sorokina

Auto-generated profile, based on publicly available information

A. V. Sorokina

Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2017 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
SKSergey Alexandrovich Kryzhanovskii
Sergey Alexandrovich Kryzhanovskii
LKL. G. Kolik
L. G. Kolik
ITI. B. Tsorin
I. B. Tsorin
VSV. N. Stolyaruk
V. N. Stolyaruk
MVM. B. Vititnova
M. B. Vititnova
ADA. D. Durnev
A. D. Durnev

27 January 2011 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
SKSergey Alexandrovich Kryzhanovskii
Sergey Alexandrovich Kryzhanovskii
ASA. V. Sorokina
A. V. Sorokina
VSV. N. Stolyaruck
V. N. Stolyaruck
MVM. B. Vititnova
M. B. Vititnova
IMI. A. Miroshkina
I. A. Miroshkina
SSS. B. Seredenin
S. B. Seredenin

1 July 2016 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
SKSergey Alexandrovich Kryzhanovskii
Sergey Alexandrovich Kryzhanovskii
LKL. G. Kolik
L. G. Kolik
ITI. B. Tsorin
I. B. Tsorin
EIE. O. Ionova
E. O. Ionova
VSV. N. Stolyaruk
V. N. Stolyaruk
IMI. A. Miroshkina
I. A. Miroshkina

10 September 2019 in Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation
Verified
Journal Article
Open access
PDF file
ASA. V. Sorokina
A. V. Sorokina
SAS. V. Alekseeva
S. V. Alekseeva
NEN. V. Eremina
N. V. Eremina
ADA. D. Durnev
A. D. Durnev
Preclinical safety evaluation is an important stage in the development of medicinal products. Clinical laboratory studies, including haematological, biochemical and pathomorphological studies, are an essential part of chronic toxicity studies. A careful choice of methodological approaches to examination of toxicological characteristics of drug candidates makes it possible to assess the degree of risk associated with their subsequent clinical use, identify potential target organs, determine the extent of damage, as well as the possibility and dynamics of restoring damaged systems. Key prerequisites for obtaining adequate results of the studies are correct methodological implementation of all the stages of sample preparation and careful consideration of all factors during interpretation of the obtained data. Thus, the choice of methodological approaches to blood tests is often determined by the species, age and sex of laboratory animals, as well as by specific characteristics of the tested drug. The aim of the study was to summarise data on haematological studies performed in the Drug Toxicology Laboratory of the Federal State Budgetary Institute «Zakusov Institute of Pharmacology» when conducting chronic toxicity studies.

3 December 2019 in Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation
Verified
Journal Article
Open access
PDF file
ASA. V. Sorokina
A. V. Sorokina
SAS. V. Alekseeva
S. V. Alekseeva
NEN. V. Eremina
N. V. Eremina
ADA. D. Durnev
A. D. Durnev
Chronic toxicity studies are an integral part of the overall toxicological evaluation of drug candidates. Biochemical studies of blood and urine serve to describe the general picture of the animal’s condition and to trace the dynamics of laboratory markers of organ damage after repeated administration of the drug — both for a group of animals, as well as individually. Pathomorphological studies of organs and tissues make it possible to understand the nature of damage at the cellular level. A systemic analysis of the data obtained allows for accurate identification of the body systems that are most susceptible to the toxic effect of the drug, as well as for assessment of the degree of impact and the reversibility of effects. Considering the great importance of the obtained pharmacological information, it is necessary to pay special attention to proper methodological implementation of all the stages of preparation and performance of the mentioned studies, as well as to proper analysis and interpretation of the data. The aim of the paper was to summarise the methodology of biochemical and pathomorphological studies based on the experience obtained in the Drug Toxicology Laboratory of the Federal State Budgetary Institute «Zakusov Institute of Pharmacology» when conducting chronic toxicity studies.

19 May 2023 in Pharmacokinetics and Pharmacodynamics
Verified
Journal Article
Open access
PDF file
ASA. V. Sorokina
A. V. Sorokina
SAS. V. Alekseeva
S. V. Alekseeva
IMI. A. Miroshkina
I. A. Miroshkina
AVA. V. Volkova
A. V. Volkova
KKK. S. Kachalov
K. S. Kachalov
ADA. D. Durnev
A. D. Durnev
Relevance. Assay of acute toxicity is a mandatory step in a preclinical safety study of medicines and pharmaceutical substances. The purpose of this study was to determine the parameters of acute toxicity of the substance GIZH-298. Methods. GIZH-298 was administered once orally to outbred mice of both sexes at doses of 350–550 mg/kg. Control mice received 0.5 ml of 1 % starch solution under the same conditions. During the experiment, the death of animals, signs of intoxication were observed, and the clinical picture was recorded. Pathological anatomical autopsy of the dead mice was performed as they died. Surviving mice were autopsied 14 days after the start of the experiment, immediately after their euthanasia. Results. The average lethal doses of the GIZh-298 substance when administered orally to mice were determined: LD50 in females was 356 mg/kg, LD50 in males was 438 mg/kg. Conclusion. Compound GIZH-298 for oral administration according to the classification of Sidorov K.K. (1973) is a moderately toxic substance and can be assigned to the 3rd class of toxicity, and in accordance with GOST 12.1.007-76 — to the 3rd hazard class.